IMMUNIC, INC. — Director's Dealing 2018

Sep 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2018-09-25

Reporting Person: Halperin Errol R. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-25	Common Stock	S	89417	$0.2901	Disposed	0	Direct
2018-09-25	Common Stock	S	10000	$0.29	Disposed	0	Indirect

Footnotes

F1: Shares held by Errol Halperin IRA FBO Errol Halperin.